1,141
Views
17
CrossRef citations to date
0
Altmetric
Research Paper

Bcl-2 family member Mcl-1 expression is reduced under hypoxia by the E3 ligase FBW7 contributing to BNIP3 induced cell death in glioma cells

, , , , , , , , & show all
Pages 604-613 | Received 03 Apr 2015, Accepted 12 Sep 2015, Published online: 13 May 2016

References

  • Gurney JG, Kadan-Lottick N. Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr Opin Oncol 2001; 13:160-6; PMID:11307058; http://dx.doi.org/10.1097/00001622-200105000-00005
  • Chamberlain MC. Treatment options for glioblastoma. Neurosurg Focus 2006; 20:E2
  • Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114:97-109; PMID:17618441; http://dx.doi.org/10.1007/s00401-007-0243-4
  • Akgul C. Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci 2009; 66:1326-36; PMID:19099185; http://dx.doi.org/10.1007/s00018-008-8637-6
  • Ding Q, He X, Xia W, Hsu JM, Chen CT, Li LY, Lee DF, Yang JY, Xie X, Liu JC, et al. Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer. Cancer research 2007; 67:4564-71; PMID:17495324; http://dx.doi.org/10.1158/0008-5472.CAN-06-1788
  • Booy EP, Henson ES, Gibson SB. Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer. Oncogene 2011; 30:2367-78; PMID:21258408; http://dx.doi.org/10.1038/onc.2010.616
  • Henson ES, Hu X, Gibson SB. Herceptin sensitizes ErbB2-overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 expression. Clin Cancer Res 2006; 12:845-53; PMID:16467098; http://dx.doi.org/10.1158/1078-0432.CCR-05-0754
  • Perciavalle RM, Opferman JT. Delving deeper: MCL-1's contributions to normal and cancer biology. Trends Cell Biol 2013; 23:22-9; PMID:23026029; http://dx.doi.org/10.1016/j.tcb.2012.08.011
  • He L, Torres-Lockhart K, Forster N, Ramakrishnan S, Greninger P, Garnett MJ, McDermott U, Rothenberg SM, Benes CH, Ellisen LW. Mcl-1 and FBW7 control a dominant survival pathway underlying HDAC and Bcl-2 inhibitor synergy in squamous cell carcinoma. Cancer Dis 2013; 3:324-37; PMID:23274910; http://dx.doi.org/10.1158/2159-8290.CD-12-0417
  • Vande Velde C, Cizeau J, Dubik D, Alimonti J, Brown T, Israels S, Hakem R, Greenberg AH. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 2000; 20:5454-68; PMID:10891486; http://dx.doi.org/10.1128/MCB.20.15.5454-5468.2000
  • Kim JY, Cho JJ, Ha J, Park JH. The carboxy terminal C-tail of BNip3 is crucial in induction of mitochondrial permeability transition in isolated mitochondria. Arch Biochem Biophys 2002; 398:147-52; PMID:11831844; http://dx.doi.org/10.1006/abbi.2001.2673
  • Kothari S, Cizeau J, McMillan-Ward E, Israels SJ, Bailes M, Ens K, Kirshenbaum LA, Gibson SB. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 2003; 22:4734-44; PMID:12879018; http://dx.doi.org/10.1038/sj.onc.1206666
  • Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci U S A 2000; 97:9082-7; PMID:10922063; http://dx.doi.org/10.1073/pnas.97.16.9082
  • Bacon AL, Harris AL. Hypoxia-inducible factors and hypoxic cell death in tumour physiology. Ann Med 2004; 36:530-9; PMID:15513303; http://dx.doi.org/10.1080/07853890410018231
  • Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 2001; 61:6669-73; PMID:11559532
  • Huelsemann MF, Patz M, Beckmann L, Brinkmann K, Otto T, Fandrey J, Becker HJ, Theurich S, von Bergwelt-Baildon M, Pallasch CP, et al. Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemia. Leukemia 2014; 29:981-984; PMID:25376373
  • Brunelle JK, Shroff EH, Perlman H, Strasser A, Moraes CT, Flavell RA, Danial NN, Keith B, Thompson CB, Chandel NS. Loss of Mcl-1 protein and inhibition of electron transport chain together induce anoxic cell death. Mol Cell Biol 2007; 27:1222-35; PMID:17145774; http://dx.doi.org/10.1128/MCB.01535-06
  • Berezowska S, Schlegel J. Targeting ErbB Receptors in High-Grade Glioma. Curr Pharm Des 2011; 17(23):2468-87; PMID:21827413
  • Azad MB, Chen Y, Henson ES, Cizeau J, McMillan-Ward E, Israels SJ, Gibson SB. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy 2008; 4:195-204; PMID:18059169; http://dx.doi.org/10.4161/auto.5278
  • Bristow N, Burton TR, Henson ES, Ong-Justiniano C, Brown M, Gibson SB. Truncated forms of BNIP3 act as dominant negatives inhibiting hypoxia-induced cell death. Biochimica et biophysica acta 2011; 1812:302-11; PMID:21138765; http://dx.doi.org/10.1016/j.bbadis.2010.11.013
  • Burton TR, Eisenstat DD, Gibson SB. BNIP3 (Bcl-2 19 kDa interacting protein) acts as transcriptional repressor of apoptosis-inducing factor expression preventing cell death in human malignant gliomas. J Neurosci 2009; 29:4189-99; PMID:19339613; http://dx.doi.org/10.1523/JNEUROSCI.5747-08.2009
  • Pitz MW, Lipson M, Hosseini B, Lambert P, Guilbert K, Lister D, Schroeder G, Jones K, Mihalicioiu C, Eisenstat DD. Extended adjuvant temozolomide with cis-retinoic acid for adult glioblastoma. Curr Oncol 2012; 19:308-14; PMID:23300356; http://dx.doi.org/10.3747/co.19.1151
  • Cassavaugh JM, Hale SA, Wellman TL, Howe AK, Wong C, Lounsbury KM. Negative regulation of HIF-1alpha by an FBW7-mediated degradation pathway during hypoxia. J Cell Biochem 2011; 112:3882-90; PMID:21964756; http://dx.doi.org/10.1002/jcb.23321
  • Thomas RL, Kubli DA, Gustafsson AB. Bnip3-mediated defects in oxidative phosphorylation promote mitophagy. Autophagy 2011; 7:775-7; PMID:21460627; http://dx.doi.org/10.4161/auto.7.7.15536
  • Giatromanolaki A, Koukourakis MI, Sowter HM, Sivridis E, Gibson S, Gatter KC, Harris AL. BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer. Clin Cancer Res 2004; 10:5566-71; PMID:15328198; http://dx.doi.org/10.1158/1078-0432.CCR-04-0076
  • Petry IB, Fieber E, Schmidt M, Gehrmann M, Gebhard S, Hermes M, Schormann W, Selinski S, Freis E, Schwender H, et al. ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancer. Clin Cancer Res 2010; 16:451-60; PMID:20068093; http://dx.doi.org/10.1158/1078-0432.CCR-09-1617
  • Burton TR, Henson ES, Baijal P, Eisenstat DD, Gibson SB. The pro-cell death Bcl-2 family member, BNIP3, is localized to the nucleus of human glial cells: Implications for glioblastoma multiforme tumor cell survival under hypoxia. Int J Cancer 2006; 118:1660-9; PMID:16217754; http://dx.doi.org/10.1002/ijc.21547
  • Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, et al. The somatic genomic landscape of glioblastoma. Cell 2013; 155:462-77; PMID:24120142; http://dx.doi.org/10.1016/j.cell.2013.09.034
  • Kayama T, Yoshimoto T, Fujimoto S, Sakurai Y. Intratumoral oxygen pressure in malignant brain tumor. J Neurosurg 1991; 74:55-9; PMID:1984507; http://dx.doi.org/10.3171/jns.1991.74.1.0055
  • Sharp FR, Bergeron M, Bernaudin M. Hypoxia-inducible factor in brain. Adv Exp Med Biol 2001; 502:273-91; PMID:11950144; http://dx.doi.org/10.1007/978-1-4757-3401-0_18
  • Sannazzari GL, Ricardi U, Filippi AR. Hypoxia and tumor response to irradiation. Rays 2002; 27:175-9; PMID:12696246
  • Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352:987-96; PMID:15758009; http://dx.doi.org/10.1056/NEJMoa043330
  • Barker FG, 2nd, Simmons ML, Chang SM, Prados MD, Larson DA, Sneed PK, Wara WM, Berger MS, Chen P, Israel MA, et al. EGFR overexpression and radiation response in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2001; 51:410-8; PMID:11567815; http://dx.doi.org/10.1016/S0360-3016(01)01609-1
  • Kleihues P, Ohgaki H. Phenotype vs genotype in the evolution of astrocytic brain tumors. Toxicol Pathol 2000; 28:164-70; PMID:10669004; http://dx.doi.org/10.1177/019262330002800121
  • Yu JL, Rak JW, Coomber BL, Hicklin DJ, Kerbel RS. Effect of p53 status on tumor response to antiangiogenic therapy. Science 2002; 295:1526-8; PMID:11859195; http://dx.doi.org/10.1126/science.1068327
  • Kelly JJ, Stechishin O, Chojnacki A, Lun X, Sun B, Senger DL, Forsyth P, Auer RN, Dunn JF, Cairncross JG, et al. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Stem cells 2009; 27:1722-33; PMID:19544433; http://dx.doi.org/10.1002/stem.98
  • Chen Y, Azad MB, Gibson SB. Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ 2009; 16:1040-52; PMID:19407826; http://dx.doi.org/10.1038/cdd.2009.49

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.